1. World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. 2nd edn. 2016.
http://apps.who.int/iris/bitstream/10665/208825/1/9789241549684_eng.pdf?ua=1
. Accessed 28 Apr 2017.
2. World Health Organization. Guidance on pre-exposure oral prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV: recommendations for use in the context of demonstration projects. 2012.
http://www.who.int/hiv/pub/guidance_prep/en/
. Accessed 25 Feb 2017.
3. US Public Health Service pre-exposure prophylaxis for the prevention of HIV infection in the United States—2014. A clinical practice guideline. 2014.
https://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf
. Accessed 25 Feb 2017.
4. AVAC. PrEPWatch: Country Updates.
http://www.prepwatch.org/scaling-up/country-updates/
. Accessed 8 Mar 2017.
5. UNAIDS Global summary of the AIDS epidemic. 2015.
http://www.who.int/mediacentre/factsheets/fs334/en/
. Accessed 8 Mar 2017.